concord Biotech LTDPicture this: Concord Biotech Ltd, a stock showing promising signs of strength. The volume is buzzing, and it's near a resistance level. It needs to spend some time there before I initiate a buy entry.
Next report date
Report period
Q4 2023
EPS estimate
9.10INR
Revenue estimate
3.14 BINR
2.40 BINR
8.31 BINR
22.53 M
About CONCORD BIOTECH LTD
Sector
Headquarters
Ahmedabad
Website
Founded
2000
FIGI
BBG01HRWT6H8
Concord Biotech Ltd. operates as a research and development based biotechnology company. It manufactures active pharmaceutical ingredients through the process of fermentation, semi-synthetic and synthetic processes. The firm''s products include APIs in the immunosuppressant, antibiotic, oncology, antifungal and hypolipemic segments and enzymes. The company was founded in 2000 and is headquartered in Ahmedabad, India.
Swing Trade In Concord NSE in 1Day TFSwing Trade In Concord NSE in 1Day TF.
Technical Analysis
The stock has reached an all-time high, surpassing its recent resistance level. Additionally, there are two levels of contraction observed in its performance.
1st Contraction is around 13.71%
2nd Contraction is around 06.10%
Target 10%
SL
Concord bio may test 1450Good volume
Maybtest new high
Target 1450
Stop 1350
Posted good sept quarter numbers
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CONCORDBIO is 1660.05 INR — it has increased by 1.45% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange CONCORD BIOTECH LTD stocks are traded under the ticker CONCORDBIO.
CONCORD BIOTECH LTD is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
CONCORDBIO stock is 2.53% volatile and has beta coefficient of 0.26. Check out the list of the most volatile stocks — is CONCORD BIOTECH LTD there?
CONCORD BIOTECH LTD revenue for the last quarter amounts to 2.62 B INR despite the estimated figure of 2.62 B INR. In the next quarter revenue is expected to reach 2.72 B INR.
Yes, you can track CONCORD BIOTECH LTD financials in yearly and quarterly reports right on TradingView.
CONCORDBIO stock has risen by 5.40% compared to the previous week, the month change is a 10.30% rise, over the last year CONCORD BIOTECH LTD has showed a 84.44% increase.
CONCORDBIO net income for the last quarter is 775.73 M INR, while the quarter before that showed 810.20 M INR of net income which accounts for −4.25% change. Track more CONCORD BIOTECH LTD financial stats to get the full picture.
No, CONCORDBIO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CONCORDBIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CONCORD BIOTECH LTD stock right from TradingView charts — choose your broker and connect to your account.
We've gathered analysts' opinions on CONCORD BIOTECH LTD future price: according to them, CONCORDBIO price has a max estimate of 1720.00 INR and a min estimate of 1410.00 INR. Read a more detailed CONCORD BIOTECH LTD forecast: see what analysts think of CONCORD BIOTECH LTD and suggest that you do with its stocks.